Immunic, Inc. , a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic diseases, today announced participation in the following investor and medical ...
Ford engineers are studying whether AI can play a role in detecting faulty run-downs. To do that, they first had to determine ...
What I see now is the formation of a new category: the Bank Operating System. This is a real-time, composable growth layer ...
A10 continued to deliver growth and profitability in the second quarter. This performance demonstrates the continued ...
Detailed price information for Geovax Labs Inc (GOVX-Q) from The Globe and Mail including charting and trades.
First quarter 2026 revenues increased 19% to $3.6 billion versus first quarter 2025Dupixent® global net sales(recorded by Sanofi) increased 33% ...
First quarter 2026 revenues increased 19% to $3.6 billion versus first quarter 2025Dupixent- global net sales (recorded by Sanofi) increased 33% to $4.9 billion EYLEA HD- U.S. net sales increased 52% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results